+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Avastin"

From
From
From
From
Brain Tumor Drugs Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Brain Tumor Drugs Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
From
From
From
Ovarian Cancer Pipeline Analysis Report - Product Thumbnail Image

Ovarian Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Small Cell Lung Cancer (SCLC) Market Report and Forecast 2024-2032 - Product Thumbnail Image

Small Cell Lung Cancer (SCLC) Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Loading Indicator

Avastin is a drug used in the treatment of certain types of cancer. It is a monoclonal antibody that works by blocking the growth of new blood vessels that tumors need to grow. Avastin is used to treat a variety of cancers, including colorectal, lung, kidney, and ovarian cancer. It is also used to treat metastatic breast cancer. Avastin is administered intravenously and is often used in combination with other cancer treatments, such as chemotherapy and radiation therapy. Avastin is a key drug in the oncology market, as it is used to treat a variety of cancers. It is one of the most widely used cancer drugs in the world, and is often used in combination with other treatments. Avastin is a valuable tool in the fight against cancer, as it can help slow the growth of tumors and prolong the lives of patients. Some of the companies in the Avastin market include Roche, Merck, Pfizer, AstraZeneca, and Novartis. Show Less Read more